Treatment of glaucoma using endothelin receptor antagonists | Patent Number 11738007
US 11738007 B2Filled DateApr 29, 2022
Priority DateOct 30, 2019
Publication DateAug 18, 2022
Expiration DateOct 29, 2039
Inventor/ApplicantsSevgi Gurkan
David Floyd
David Floyd
ExaminesANTHOPOLOS, PETER
Art Unit1611
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.